and its utilization in the distinguishing grade I astrocytoma from reactive gliosis was limited.
Distinguishing grade 1 chondrosarcoma from grade 2 chondrosarcoma is critical both for planning the surgical procedure and for predicting the outcome.
Finally, for independent analysis of microarray data as validated data sets, these hub genes can provide excellent diagnostic power in distinguishing grade, type, and stage of ECs.
Clinically, distinguishing grade II from grade III gliomas is very important because the prognoses for patients with grade II gliomas are significantly better than for patients with grade III gliomas [ 22].
>>> -wrap-foot> computedtomographyaphy, MRI magnetic resonance imaging, PPV positive predictive value Although several studies have reviewed the differentiation criteria of grade 1 chondrosarcoma from enchondroma [ 13, 16, 18, 20– 24], distinguishing grade 2 chondrosarcoma from grade 1 chondrosarcoma has hardly been discussed.
In addition, a number of novel hub genes in these two co-expression networks were identified contributing to three signaling pathways: cell-cycle regulation, antigen processing and TCA cycle, and presented a high predictive power in distinguishing grade, type and stage of ECs.
With lowest cusp slopes displaying similar orientations to those of the grade B, Grade C can be now morphologically distinguished from Grade D. However, no crown topographic parameter distinguishes grades B and O, which both display cusp interlocking, but have different directions of masticatory movements.
Based on the presence or absence of malignant features: cell density, nuclear atypia, mitosis, microvascular proliferation, and necrosis, the WHO classification distinguishes grades I, II (LGG), III (anaplastic), and IV (glioblastomas, GBM) [ 2].
Within the group of HGGs, the last 2007 WHO classification distinguishes grade 4 GBMs (astrocytomas) from grade 3 AG using their highly infiltrative characteristics.
This data could be used to diagnose PHNETS and distinguish grade 1 and 2 tumors from grade 3 tumors, which typically show multiplicity and central necrosis.
